SEC 13F Intelligence

Altium Capital Management LLC / ESPR

Altium Capital Management LLC’s Esperion Therapeutics Inc Ne Position

Does Altium Capital Management LLC own Esperion Therapeutics Inc Ne (ESPR)? Not currently — the last reported position was 620.0K shares worth $4M in Q4 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$4M
Q4 2022
Shares
620.0K
% of Portfolio
+1.96%
Quarters Held
5
position exited

Position History ESPR

Reported value by quarter
Q4 ’21: $13MQ4 ’21Q1 ’22: $12MQ1 ’22Q2 ’22: $7MQ2 ’22Q3 ’22: $4MQ3 ’22Q4 ’22: $4MQ4 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2022620.0K$4M+1.96%
Q3 2022659.9K$4M+1.62%
Q2 20221.16M$7M+2.96%
Q1 20222.50M$12M+3.88%
Q4 20212.52M$13M+3.47%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of ESPR.